CClinicalTrials.gg
CompletedNCT02081456Updated Oct 23, 2018Results posted

Soft Tissue Mobilization Versus Therapeutic Ultrasound for Subjects With Neck and Arm Pain

An interventional study of Soft Tissue Mobilization and Therapeutic Ultrasound in Cervical Radiculopathy, sponsored by Emilio J Puentedura, PT, DPT, PhD. Completed. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2018-10-23.

Sponsored by Emilio J Puentedura, PT, DPT, PhD · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
23
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to investigate effects of soft tissue mobilization versus therapeutic ultrasound in subjects with neck and arm pain who demonstrate neural mechanical sensitivity.

Read the detailed description

To investigate the immediate effects of soft tissue mobilization (STM) versus therapeutic ultrasound (US) in patients with neck and arm pain who demonstrate neural mechanical sensitivity. Twenty-three patients with neck and arm pain and a positive upper limb neurodynamic test (ULNT) were randomly assigned to receive STM or therapeutic US during a single session. Outcome measures were collected immediately before and after treatment, and at 2-4 day follow-up. Primary outcomes were the Global Rating of Change (GROC), range of motion (ROM) during the ULNT, and pain rating during the ULNT. Secondary measures included the Neck Disability Index (NDI), Patient-Specific Functional Scale (PSFS), Numeric Pain Rating Scale (NPRS), and active range of shoulder abduction motion combined with the wrist neutral or wrist extension.

02

Conditions studied

  • Cervical Radiculopathy

Browse trials for

03

In context

Radiculopathy

488 studies on the registry are indexed under Radiculopathy; 141 are open to participants now.

This study's enrollment of 23 is below the median of 60 across 376 interventional studies indexed under Radiculopathy.

Browse Radiculopathy studies →

Lead sponsor

This is the only study on the registry with Emilio J Puentedura, PT, DPT, PhD as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Active movement dysfunction that could be related to mechanical sensitivity of the neural structures of the upper limb. (i.e. painful shoulder abduction with elbow extension that is limited more when the wrist is extended than when the wrist is in neutral.)
  2. Positive response to upper limb neural provocation testing (ULNT 1) (see description below for details)
  3. Tenderness to palpation over the cervical nerve trunks, brachial plexus, or along the median nerve.
  4. Tender points or taut bands in the muscles of the upper quadrant including the scalenes, cervical paraspinals, trapezius, deltoid, pectoralis major or minor, rotator cuff, biceps, triceps, coracobrachialis, brachialis, radiobrachialis, pronator teres, supinator, forearm extensor, forearm flexor, pronator quadratus, and hand intrinsic muscles.

Exclusion criteria

Exclusion Criteria:

  1. Red flags noted in the medical screening questionnaire such as tumor, fracture, history of metabolic disease, prolonged history of corticosteroid use.
  2. Signs of central nervous system involvement such as hyper-reflexia (exaggerated response to deep tendon reflex testing), unsteadiness during gait, ataxia, disturbed vision, nystagmus, altered taste, positive Babinski's or Hoffman's reflexes.
  3. Cervical spine surgery within the last 3 months.
  4. Litigation associated with their neck and/or upper limb pain.
  5. Insufficient English language skills to complete the questionnaires and follow-up instructions.
  6. Inability to complete the treatment and follow-up schedule.
  7. Current pregnancy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
23 participants (actual)

Study arms

  • Active comparator
    Therapeutic Ultrasound

    Therapeutic ultrasound applied for a period of 5 minutes to the most painful region of the neck, then a second 5 minute dose at the most painful region of the upper extremity

    Device: Therapeutic Ultrasound

  • Experimental
    Soft Tissue Mobilization

    Passive soft tissue mobilization to the neck and upper extremity

    Other: Soft Tissue Mobilization

Interventions

  • OtherSoft Tissue Mobilization

    Patients in the STM group received treatment in supine, with their head resting on one pillow and the involved UE positioned in abduction and external rotation to preload the neural structures of the upper limb. Manual pressure was applied to the soft tissues of the upper quadrant in a deep, stroking manner with the intention to improve the mobility of the soft tissues surrounding the pathway of the neural structures of the upper limb as well as any tender or tight tissues. The therapist spent approximately 7 minutes on the neck and scapular region, 4 minutes on the upper arm, and 4 minutes on the forearm and hand. The therapist was allowed to vary the time spent on each region according to his/her assessment of the patient's condition. The procedure lasted a total of 15 minutes.

  • DeviceTherapeutic Ultrasound

    Patients received therapeutic US applied for a period of 5 minutes to the most painful region of the neck, then a second 5-minute dose at the most painful region of the upper extremity. The US dose was 0.5 w/cm2, with sonation time 50% and frequency 1 MHz.40,52 The patient lay supine with the hand of the involved upper extremity placed on the abdomen and the elbow supported on a pillow. The two US doses and interaction time with the patient lasted a total of 15 minutes in an attempt to have equal patient/therapist contact between the two groups.

06

What researchers measure

Primary outcomes

  1. Upper Limb Neurodynamic Tesnion (UNLT) Range of Motion

    Time frame: up to 2-4 day follow up

  2. Numeric Pain Rating Scale

    Measures perceived level of pain on a scale from 0 to 10, where 0 indicates 'no pain' and 10 indicates 'worst imaginable pain'. Therefore, lower scores are better. Outcome results are given and mean changes from pre to post interventions, therefore, a negative value indicates improvement.

    Time frame: up to 2-4 day follow up

Secondary outcomes

  1. Neck Disability Index

    Measure of perceived disability on a scale of 0 to 50, where 0 indicates no disability and 50 indicates maximum disability. Therefore, lower scores are better. Outcome results are given and mean changes from pre to post interventions, therefore, a negative value indicates improvement.

    Time frame: 2-4 day follow up

  2. Patient Specific Functional Scale

    Perceived ability to perform specific activities on a scale of 0 to 30, where 0 indicates complete inability to perform and 30 indicates able to perform activity at the same level as before injury or problem. Therefore higher scores are better. Outcome results are given and mean changes from pre to post interventions, therefore, a positive value indicates improvement.

    Time frame: at 2-4 day follow up

07

Results

Posted Oct 23, 2018

Participant flow

Between November 2009 and June 2012 consecutive patients with neck and arm pain presenting to Cayuga Medical Center's Physical Therapy Department were screened for eligibility criteria

Participant flow — Overall Study
MilestoneTherapeutic UltrasoundSoft Tissue Mobilization
Started1112
Completed1112
Not completed00

Outcome measures

PrimaryUpper Limb Neurodynamic Tesnion (UNLT) Range of Motion
Time frame:
up to 2-4 day follow up
Reported as:
Mean · degrees
Upper Limb Neurodynamic Tesnion (UNLT) Range of Motion
degreesTherapeutic UltrasoundSoft Tissue Mobilization
Upper Limb Neurodynamic Tesnion (UNLT) Range of Motion4.60 (-0.60 to 9.80)16.00 (9.88 to 22.12)
PrimaryNumeric Pain Rating Scale

Measures perceived level of pain on a scale from 0 to 10, where 0 indicates 'no pain' and 10 indicates 'worst imaginable pain'. Therefore, lower scores are better. Outcome results are given and mean changes from pre to post interventions, therefore, a negative value indicates improvement.

Time frame:
up to 2-4 day follow up
Reported as:
Mean · units on a scale
Numeric Pain Rating Scale
units on a scaleTherapeutic UltrasoundSoft Tissue Mobilization
Numeric Pain Rating Scale-0.80 (-2.18 to 0.58)-1.31 (-2.10 to -0.51)
SecondaryNeck Disability Index

Measure of perceived disability on a scale of 0 to 50, where 0 indicates no disability and 50 indicates maximum disability. Therefore, lower scores are better. Outcome results are given and mean changes from pre to post interventions, therefore, a negative value indicates improvement.

Time frame:
2-4 day follow up
Reported as:
Mean · units on a scale
Neck Disability Index
units on a scaleTherapeutic UltrasoundSoft Tissue Mobilization
Neck Disability Index-1.20 (-5.63 to 3.23)-6.00 (-12.55 to 0.55)
SecondaryPatient Specific Functional Scale

Perceived ability to perform specific activities on a scale of 0 to 30, where 0 indicates complete inability to perform and 30 indicates able to perform activity at the same level as before injury or problem. Therefore higher scores are better. Outcome results are given and mean changes from pre to post interventions, therefore, a positive value indicates improvement.

Time frame:
at 2-4 day follow up
Reported as:
Mean · units on a scale
Patient Specific Functional Scale
units on a scaleTherapeutic UltrasoundSoft Tissue Mobilization
Patient Specific Functional Scale0.30 (-0.16 to 0.76)1.67 (0.80 to 2.53)

Adverse events

Collected over Baseline to 2 - 4 days follow up. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Therapeutic Ultrasound—0/11 (0%)0/11 (0%)
Soft Tissue Mobilization—0/12 (0%)0/12 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Therapeutic UltrasoundSoft Tissue MobilizationTotal
Mean42.00 ± 10.4246.25 ± 10.4244.22 ± 10.24
Sex: Female, Male
Sex: Female, Male(Participants)Therapeutic UltrasoundSoft Tissue MobilizationTotal
Female101121
Male112
08

Study locations

No study locations are listed for this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 23, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02081456
Lead sponsor
Emilio J Puentedura, PT, DPT, PhD
Responsible party
Emilio J Puentedura, PT, DPT, PhD (Co-Principal Investigator, University of Nevada, Las Vegas) — Sponsor-investigator
First posted
Mar 7, 2014
Start date
Nov 2009
Primary completion
Jun 2012
Completion
Jun 2012
Results posted
Oct 23, 2018
Last update
Oct 23, 2018

Study contacts

Michael Costello, PT, DSc
principal investigator · Rocky Mountain University Health Sciences
Emilio j Puentedura, PT, DPT, PhD
study director · UNLV

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion